Rchr
J-GLOBAL ID：201801014572940372
Update date: Apr. 22, 2024
YAMAGUCHI Motoko
ヤマグチ モトコ | YAMAGUCHI Motoko
Affiliation and department：
Job title：
Professor
Research field (1)：
Hematology and oncology
Research theme for competitive and other funds (4)：
- 2020 - 2023 国際共同によるNK/T細胞リンパ腫の病態比較と治療最適化
- 2017 - 2020 Elucidation of mechanism of lymphomagenesis and identification of tumor origin in duodenal follicular lymphoma
- 2017 - 2020 Optimization of new generation therapy for NK/T-cell lymphoma in East Asia
- 2014 - 2017 NKEA project: Next-Generation Therapy for NK/T-cell lymphoma in East Asia
Papers (148)：
-
Takashi Watanabe, Yoshihiro Matsuno, Masashi Wakabayashi, Dai Maruyama, Kazuhito Yamamoto, Nobuko Kubota, Kazuyuki Shimada, Kohsuke Asagoe, Motoko Yamaguchi, Kiyoshi Ando, et al. Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203. Hematological oncology. 2024. 42. 3. e3272
-
Takashi Watanabe, Kensei Tobinai, Masaki Wakabayashi, Dai Maruyama, Kazuhito Yamamoto, Nobuko Kubota, Kazuyuki Shimada, Kohsuke Asagoe, Motoko Yamaguchi, Kiyoshi Ando, et al. R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203. British Journal of Haematology. 2023
-
Kana Miyazaki, Rika Sakai, Noriko Iwaki, Go Yamamoto, Kayoko Murayama, Momoko Nishikori, Kazutaka Sunami, Isao Yoshida, Hiroki Yano, Naoki Takahashi, et al. Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL. Cancer science. 2023. 114. 6. 2689-2691
-
Yuma Nato, Kana Miyazaki, Hiroshi Imai, Eri Nakano, Yuki Kageyama, Kazuko Ino, Atsushi Fujieda, Takeshi Matsumoto, Isao Tawara, Kyosuke Tanaka, et al. Correction to: Early central nervous system relapse of monomorphic epitheliotropic intestinal T-cell lymphoma after cord blood transplantation. International journal of hematology. 2022. 115. 3. 452-453
-
Kana Miyazaki, Ritsuro Suzuki, Masahiko Oguchi, Senzo Taguchi, Jun Amaki, Takeshi Maeda, Nobuko Kubota, Dai Maruyama, Yasuhito Terui, Nodoka Sekiguchi, et al. Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma. Hematological oncology. 2022. 40. 4. 667-677
ｍore...
MISC (190)：
-
Takashi Watanabe, Kensei Tobinai, Masashi Wakabayashi, Dai Maruyama, Kazuhito Yamamoto, Nobuko Kubota, Kazuyuki Shimada, Kohsuke Asagoe, Motoko Yamaguchi, Kiyoshi Ando, et al. Final Analysis of JCOG0203 for Advanced-Stage Indolent B-Cell Lymphoma 15 Years after the End of Enrollment: Pooled Analysis of Arms a and B for Follicular Lymphoma. BLOOD. 2022. 140. 3615-3617
-
山口 素子. 【がん診療の最新知見】T細胞リンパ腫 T/NK細胞リンパ腫 総論. クリニシアン. 2022. 69. 4. 392-397
-
山口 素子. 【最新の造血器腫瘍疾患診療〜一般内科医に役立つ診断から外来治療の流れ〜】悪性リンパ腫の初期診断と外来治療. 日本内科学会雑誌. 2022. 111. 7. 1378-1383
-
山口 素子. 【血液疾患のすべて】悪性リンパ腫と類縁疾患 NK/T細胞リンパ腫. 日本医師会雑誌. 2022. 151. 特別1. S269-S270
-
近藤 奈生, 宮崎 香奈, 今井 裕, 俵 功, 山口 素子. 未治療CD5陽性びまん性大細胞型B細胞リンパ腫に対するPEARL5型治療 単施設での検討. 日本リンパ網内系学会会誌. 2022. 62. 113-113
ｍore...
Lectures and oral presentations (13)：
-
Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study)
(BLOOD 2022)
-
Final Analysis of JCOG0203 for Advanced-Stage Indolent B-Cell Lymphoma 15 Years after the End of Enrollment: Pooled Analysis of Arms a and B for Follicular Lymphoma
(BLOOD 2022)
-
TP53陽性の真性多血症後急性白血病に対し、ベネトクラクス+アザシチジン療法でTP53クローン消失を得た一例
(日本血液学会学術集会 2022)
-
未治療CD5陽性びまん性大細胞型B細胞リンパ腫に対するPEARL5型治療 単施設での検討
(日本リンパ網内系学会会誌 2022)
-
liquid biopsyを契機に診断されたintravascular large B-cell lymphoma
(日本リンパ網内系学会会誌 2022)
ｍore...
Professional career (1)：
Return to Previous Page
